Hybrid protein between CS from plasmodium and HBsAg

Details Hybrid protein between CS from plasmodium and HBsAg Hybrid protein between CS from plasmodium and HBsAg

1996-12-04

1999-07-27

Minnifield, Nita

Chemistry: molecular biology and microbiology

Micro-organism, tissue cell culture or enzyme using process...

Recombinant dna technique included in method of making a...

4241841, 4241891, 4241921, 4242271, 4242721, 514 2, 530350, C12P 2106, A61K 3900, A61K 3929, C07K 1400

Patent

active

059289023

ABSTRACT:
A novel hybrid protein is provided which comprises a portion of the CS protein of P. falciparum and the surface antigen of Hepatitis B virus. The use of this protein for vaccination purposes is disclosed.

REFERENCES:
patent: 4722840 (1988-02-01), Valenzuela et al.
patent: 4886782 (1989-12-01), Good et al.
patent: 4912094 (1990-03-01), Myers et al.
patent: 5112749 (1992-05-01), Brey et al.
patent: 5164485 (1992-11-01), Yukio et al.
patent: 5198348 (1993-03-01), Bitter
patent: 5395614 (1995-03-01), Knapp et al.
patent: 5436139 (1995-07-01), Rutter et al.
patent: 5614194 (1997-03-01), Colman et al.
Neurath et al. 1984. Science 224:392-395.
Valenzuela et al. 1979. Nature. 280:815-819.
Herrington et al. 1987. Nature 328:257-259.
Rutgers et al. 1988 Bio/Technology 6:1065-70.
Veseden et al. 1991. Am J. Trop. Med. Hyg. 45(5):533-38.
Hoffman et al. 1987. Science. 237:639-642.
Cox. 1991. TIBTECH. 9:389-394.
Hoffman et al. 1993. In. Molecular Immunol. Considerations in Malarial Vaccine Dev. Ed. Good & Saul. pp. 149-167.
Charsenvit et al. 1991. Science. 251:668-671.
Butcher. 1989. Parasitology 98:315-327.
Smith et al. 1988. Technological Advances in Vaccine Development. pp. 651-659.
Lowell et al. 1988. Science. 240:800-802.
Romero, 1992. Current Opinion in Immunol, 4:432-441.
Schodel et al, 1996, J. Biotechnology, 44:91-96.
Schodel, et al, 1996, Adv. in Exptal, Med. & Biol. 397:15-21.
Bathurst. 1994, Am. J. Trop. Med & Hyg., 50(4) Suppl.:20-26.
Stoute et al, 1997, New Eng. J. Med. 336:86-91.
Caspers et al., "The Circumsporozoite Protein Gene From NF54, a Plasmodium falciparum Isolate Used in Malaria Vaccine Trials", Molecular and Biochemical Parasitology, vol. 35, pp. 185-190 (1989).
Cheng et al., "Expression of Malaria Circumsporozoite Protein and Hepatitis-B Virus Surface Antigen by Infectious Vaccinia Virus", Vaccines 86 New Approaches to Immunization, Eds. Fred Brown et al., pp. 165-168 (1986).
de Wilde et al., "Production of Viral Antigens in Yeast . . . Saccharomyces Cerevisiae", 8th Int. Biotechnol. Symp.; (1988) Pt. 2, p. 695 (Conference Abstract).
Luciw et al., "Antigen Presentation by Way of Hepatitis B Virus Surface . . . Parasite Antigens", Mod. Approaches Vaccine, (1985) Meet., 60 (Conference Abstract).
Rutgers et al., "Hepatitis B Surface Antigen as Carrier Matrix for the Repetitive Epitope of the Circumsporozoite Protein of Plasmodium falciparum", Bio/Technology, vol. 6, pp. 1065-1070 (1988).
G. Smith and B. Moss, "Vaccinia Virus Recombinants as Live Vaccine Against Hepatitis B Virus and Malaria", Vaccinia Virus Vector Vaccine Antigen; (1985) pp. 129-136 (Conference Abstract).
von Brunn et al., "Epitopes of the Human Malaria Parasite P. falciparum Carried on the Surface of HbsAg Particles Elicit an Immune Response . . . the Parasite", Vaccine, vol. 9(7), pp. 477-484 (1991).
Young et al., "Expression of Plasmodium falciparum Circumsporozoite Proteins in Escherichia coli for Potential Use in a Human Malaria Vaccine", Science, vol. 228, pp. 958-962 (1985).
White, et al., "Induction of Cytolytic Cells by Recombinantly Co-Expressed Circumsporozoite Protein Fragment of Plasmodium Falciparum and Hepatitis B Particles", American Journal of Tropical Medicine and Hygiene, vol. 47, No. 4 SU, pp. 96-97 (1992) (Conference Abstract).
Mar. 6, 1991 Response to a communication from the European Patent Office Examining Division, pp. 1-6.

Affiliated with

Also associated with

Rating

Hybrid protein between CS from plasmodium and HBsAg does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Hybrid protein between CS from plasmodium and HBsAg, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Hybrid protein between CS from plasmodium and HBsAg will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-877660